Estimated Revenue: $1M to $10M
Last Funding Date: 2019-04-18
Investors Number: 14.0
Industry: Neurodegenerative disease diagnosis and treatment
Funding Status: Early Stage Venture
Technology: Biopharma, Biotechnology, Medical, Pharmaceutical
Employee Number: 11-50
Headquarters: Waltham, Massachusetts, United States
Last Funding Type: Series B
Total Funding: 113000000.0
Founded Date: 2015-01-01